Zeng T - Search Results

1

ATM deficiency promotes progression of CRPC by enhancing Warburg effect.

Xu L, Ma E, Zeng T, Zhao R, Tao Y, Chen X, Groth J, Liang C, Hu H, Huang J. Xu L, et al. Among authors: zeng t. Endocr Relat Cancer. 2019 Jan 1;26(1):59-71. doi: 10.1530/ERC-18-0196. Endocr Relat Cancer. 2019. PMID: 30400006 Free PMC article.

2

Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer.

Tsai YC, Zeng T, Abou-Kheir W, Yeh HL, Yin JJ, Lee YC, Chen WY, Liu YN. Tsai YC, et al. Among authors: zeng t. Mol Cancer. 2018 Feb 19;17(1):42. doi: 10.1186/s12943-018-0785-1. Mol Cancer. 2018. PMID: 29455655 Free PMC article.

3

Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer.

Chen WY, Zeng T, Wen YC, Yeh HL, Jiang KC, Chen WH, Zhang Q, Huang J, Liu YN. Chen WY, et al. Among authors: zeng t. Cancer Lett. 2019 Jan;440-441:35-46. doi: 10.1016/j.canlet.2018.10.004. Epub 2018 Oct 9. Cancer Lett. 2019. PMID: 30312731

4

N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.

Yin Y, Xu L, Chang Y, Zeng T, Chen X, Wang A, Groth J, Foo WC, Liang C, Hu H, Huang J. Yin Y, et al. Among authors: zeng t. Mol Cancer. 2019 Jan 18;18(1):11. doi: 10.1186/s12943-019-0941-2. Mol Cancer. 2019. PMID: 30657058 Free PMC article.

5

Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway.

Yin Y, Xu L, Chang Y, Zeng T, Chen X, Wang A, Groth J, Foo WC, Liang C, Hu H, Huang J. Yin Y, et al. Among authors: zeng t. Mol Cancer. 2019 Jun 19;18(1):107. doi: 10.1186/s12943-019-1034-y. Mol Cancer. 2019. PMID: 31217018 Free PMC article.

6

Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2.

Tsai YC, Chen WY, Abou-Kheir W, Zeng T, Yin JJ, Bahmad H, Lee YC, Liu YN. Tsai YC, et al. Among authors: zeng t. Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1717-1727. doi: 10.1016/j.bbadis.2018.02.016. Epub 2018 Mar 21. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29477409 Free article.

7

Inhibition of E-cadherin expression by lnc-RNA H19 to facilitate bladder cancer metastasis.

Zhu Z, Xu L, Wan Y, Zhou J, Fu D, Chao H, Bao K, Zeng T. Zhu Z, et al. Among authors: zeng t. Cancer Biomark. 2018;22(2):275-281. doi: 10.3233/CBM-170998. Cancer Biomark. 2018. PMID: 29614625

8

RAB14 activates MAPK signaling to promote bladder tumorigenesis.

Chao H, Deng L, Xu F, Fu B, Zhu Z, Dong Z, Liu YN, Zeng T. Chao H, et al. Among authors: zeng t. Carcinogenesis. 2019 Nov 25;40(11):1341-1351. doi: 10.1093/carcin/bgz039. Carcinogenesis. 2019. PMID: 30809635

9

Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis.

Liu X, Wu Y, Zhou Z, Huang M, Deng W, Wang Y, Zhou X, Chen L, Li Y, Zeng T, Wang G, Fu B. Liu X, et al. Among authors: zeng t. Int J Mol Med. 2019 Aug;44(2):683-693. doi: 10.3892/ijmm.2019.4241. Epub 2019 Jun 12. Int J Mol Med. 2019. PMID: 31198976 Free PMC article.

10

miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.

Zeng T, Peng L, Chao C, Fu B, Wang G, Wang Y, Zhu X. Zeng T, et al. Int J Clin Exp Pathol. 2014 Oct 15;7(11):7653-62. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25550801 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,381 results

Search Page

Filters